In patients with IBS, immune system activation in the colonic mucosa has been observed, accompanied by immune cell infiltration and the release of pro-inflammatory cytokines, including IL-6, TNF-α, IL-17, and IL-1β, among others [9,11,12]. This evidence concerns the gene TNF and irritable bowel syndrome.